SIGLENT(688112)2025-04-23 09:55Financial Performance - The company's revenue for Q1 2025 reached ¥131,805,218.52, representing a year-on-year increase of 26.93%[4] - Net profit attributable to shareholders increased by 33.96% year-on-year, amounting to ¥40,690,241.02[4] - The net profit after deducting non-recurring gains and losses grew by 34.00%, totaling ¥39,774,036.34[4] - Total operating revenue for Q1 2025 reached ¥131,805,218.52, a 27% increase from ¥103,844,597.71 in Q1 2024[24] - Net profit for Q1 2025 was ¥40,690,241.02, up 34% from ¥30,374,251.24 in Q1 2024[25] - Operating profit for Q1 2025 was ¥41,349,200.21, a 22% increase from ¥33,780,799.98 in Q1 2024[24] - The total comprehensive income for Q1 2025 was ¥41,080,079.82, compared to ¥30,454,182.06 in Q1 2024, marking a 35% increase[25] - Basic and diluted earnings per share increased by 36.84%, reaching ¥0.26 per share[4] - Basic and diluted earnings per share for Q1 2025 were both ¥0.26, an increase from ¥0.19 in Q1 2024[25] Cash Flow and Investments - Operating cash flow for the period surged by 188.10%, reaching ¥49,768,179.10, primarily due to increased collections and interest income[4] - Cash flow from operating activities for Q1 2025 was ¥49,768,179.10, significantly higher than ¥17,274,769.01 in Q1 2024[28] - The net increase in cash and cash equivalents for Q1 2025 was ¥42,675,311.90, compared to ¥8,181,591.15 in Q1 2024[29] - The cash flow from investing activities for Q1 2025 was -¥8,246,400.57, compared to -¥5,025,575.25 in Q1 2024, indicating increased investment outflows[28] - The net cash flow from investing activities was -$10,822,724.39, compared to -$4,751,672.56 in the previous period, indicating a significant increase in investment outflows[38] - The total cash outflow from investment activities was $10,822,724.39, highlighting a strategic shift towards capital expenditures[38] Research and Development - R&D investment totaled ¥26,123,781.91, a 25.37% increase year-on-year, accounting for 19.82% of revenue[4][5] - Research and development expenses increased to ¥26,123,781.91, representing a 25% rise compared to ¥20,836,638.20 in Q1 2024[24] - Research and development expenses for Q1 2025 were ¥26,123,781.91, up 25.3% from ¥20,836,638.20 in Q1 2024[35] Product Performance - High-end product revenue grew by 86.60%, significantly contributing to the overall revenue increase[6] - The average selling price of the company's four main product categories increased by 9.51% year-on-year[6] - The proportion of high-end products in total revenue rose by 8.85 percentage points, with high-end, mid-range, and low-end products accounting for 29%, 48%, and 23% respectively[6] Assets and Liabilities - The company's total current assets as of March 31, 2025, amount to ¥1,572,311,055.21, an increase from ¥1,561,805,792.36 at the end of 2024[19] - Total assets as of March 31, 2025, are ¥1,689,424,987.07, up from ¥1,677,191,995.38[20] - Total liabilities decreased to ¥114,576,046.91 from ¥143,914,492.17[20] - The company reported a decrease in accounts payable from ¥46,697,437.27 to ¥36,270,051.16[20] - The non-current liabilities decreased from ¥38,544,997.63 to ¥34,365,482.35[20] - The capital reserve increased slightly from ¥1,094,490,398.58 to ¥1,094,981,755.71[20] - The company's total equity rose to ¥1,523,526,404.33 from ¥1,480,060,696.00, an increase of 2.9%[33] Shareholder Information - Total number of common shareholders at the end of the reporting period is 5,611[15] - The largest shareholder, Qin Ke, holds 35,527,113 shares, representing 22.32% of total shares[15] - The company has no significant changes in the shareholder structure or share lending activities during the reporting period[16] Miscellaneous - The company is set to implement new accounting standards starting in 2025, which may impact future financial reporting[38]